Glycolysis revisited.
Glycolysis is usually considered as a paradigm metabolic pathway, due to the fact that it is present in most organisms, and also because it is the pathway by which an important nutrient, glucose, is consumed. Far from being completely understood, the regulation of this pathway witnessed several important progresses during the last few years. One of these is the discovery of fructose 2,6-bisphosphate, a potent stimulator of phosphofructokinase and inhibitor of fructose-1,6-bisphosphatase. Originally found in the liver during the course of a study on the mechanism by which glucagon acts on gluconeogenesis, this compound is now recognized as a major element in the control of glycolysis and/or gluconeogenesis in many cell types and in various organisms. The other finding is that of a regulatory protein that modulates the activity of glucokinase, the enzyme that phosphorylates glucose in the liver and in the beta cells of pancreatic islets.
Van Schaftingen
E
E
Laboratoire de Chimie Physiologique, International Institute of Cellular and Molecular Pathology, Brussels, Belgium.
D000818:Animals; D006597:Fructose-Bisphosphatase / Q000037:antagonists & inhibitors / Q000378:metabolism; D005635:Fructosediphosphates / Q000378:metabolism / Q000494:pharmacology; D005943:Gluconeogenesis; D006019:Glycolysis; D006801:Humans; D008099:Liver / Q000201:enzymology; D008954:Models, Biological; D010732:Phosphofructokinase-1 / Q000378:metabolism
D005635:Fructosediphosphates; C027652:fructose 2,6-diphosphate; D010732:Phosphofructokinase-1; D006597:Fructose-Bisphosphatase